Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $35.1000 (-0.59%) ($34.5400 - $35.4600) on Mon. Jan. 18, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.29% (three month average) | RSI | 23 | Latest Price | $35.1000(-0.59%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX declines -0.6% a day on average for past five trading days. | Weekly Trend | BAX declines -4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) (0%) (0%) (0%) (0%) (0%) | Factors Impacting BAX price | BAX will decline at least -0.645% in a week (0% probabilities). (0%) (0%) (0%) (0%) (0%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.645% (StdDev 1.29%) | Hourly BBV | 0 () | Intraday Trend | 1.5% | | | |
|
1 - 5 Day Possible Target | $29.54(-15.84%) | Resistance Level | $36.89 | 5 Day Moving Average | $35.26(-0.45%) | 10 Day Moving Average | $36.06(-2.66%) | 20 Day Moving Average | $36.89(-4.85%) | To recent high | -9% | To recent low | 3.2% | Market Cap | $N/A | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |